Canada markets open in 2 hours 37 minutes

Zentalis Pharmaceuticals, Inc. (ZNTL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.79-0.28 (-2.32%)
At close: 04:00PM EDT
11.79 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 837.25M
Enterprise Value 390.88M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)19.88
Price/Book (mrq)1.82
Enterprise Value/Revenue 9.64
Enterprise Value/EBITDA -2.95

Trading Information

Stock Price History

Beta (5Y Monthly) 1.83
52-Week Change 3-55.91%
S&P500 52-Week Change 328.04%
52 Week High 331.46
52 Week Low 39.56
50-Day Moving Average 313.23
200-Day Moving Average 316.01

Share Statistics

Avg Vol (3 month) 3774.34k
Avg Vol (10 day) 3580.9k
Shares Outstanding 571.01M
Implied Shares Outstanding 671.01M
Float 851.22M
% Held by Insiders 13.71%
% Held by Institutions 1120.74%
Shares Short (Apr 30, 2024) 417.5M
Short Ratio (Apr 30, 2024) 424.88
Short % of Float (Apr 30, 2024) 449.80%
Short % of Shares Outstanding (Apr 30, 2024) 424.65%
Shares Short (prior month Mar 28, 2024) 415.53M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-61.06%

Management Effectiveness

Return on Assets (ttm)-24.93%
Return on Equity (ttm)-51.87%

Income Statement

Revenue (ttm)40.56M
Revenue Per Share (ttm)0.59
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -207.45M
Net Income Avi to Common (ttm)-218.9M
Diluted EPS (ttm)-3.26
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)488.98M
Total Cash Per Share (mrq)6.89
Total Debt (mrq)45.35M
Total Debt/Equity (mrq)9.89%
Current Ratio (mrq)9.19
Book Value Per Share (mrq)6.46

Cash Flow Statement

Operating Cash Flow (ttm)-210.51M
Levered Free Cash Flow (ttm)-75.02M